The cytokinesis-block micronucleus cytome (CBMN-cyt) assay was originally established as an ideal system for evaluating chromosomal damage in terms of micronuclei formation. Throughout the years, the micronucleus assay evolved in a comprehensive system for assessing cytogenetic damage, cytostasis and cytotoxicity. The CBMN-cyt assay in peripheral blood lymphocytes and in other cultured mammalian cells is the most common approach to evaluate chromosomal damage induced by environmental agents, including emerging compounds as nanomaterials, and it is the most frequent test system in biomonitoring human populations.When coupled with fl uorescence in situ hybridization (FISH), CBMN-cyt assay is able to reveal the capability to induce structural chromosome aberrations (clastogenic activity) and/or numerical chromosome changes (aneuploidogenic activity).The methods for CBMN-cyt assay and FISH described here refer to the use of separate lymphocytes and whole blood cultures involving the block of cytokinesis with cytochalasin B (cyt-B) but other cell systems of different origin can be successfully used. This chapter describes in details well-established protocols for sample processing, slide preparation and scoring criteria.